• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy: Topotecan or treosulfan--that is the question.

作者信息

Markman Maurie

出版信息

Nat Rev Clin Oncol. 2009 Oct;6(10):559-60. doi: 10.1038/nrclinonc.2009.144.

DOI:10.1038/nrclinonc.2009.144
PMID:19786996
Abstract
摘要

相似文献

1
Chemotherapy: Topotecan or treosulfan--that is the question.
Nat Rev Clin Oncol. 2009 Oct;6(10):559-60. doi: 10.1038/nrclinonc.2009.144.
2
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).拓扑替康与烷化剂曲奥舒凡用于一线铂类/紫杉醇化疗后12个月内复发的上皮性卵巢癌患者的疗效对比。由妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究组（AGO-OVAR）进行的一项前瞻性随机III期试验。
Gynecol Oncol. 2009 Aug;114(2):199-205. doi: 10.1016/j.ygyno.2009.04.026. Epub 2009 May 14.
3
Extending the platinum-free interval in recurrent ovarian cancer: the role of topotecan in second-line chemotherapy.延长复发性卵巢癌的无铂间期：拓扑替康在二线化疗中的作用。
Oncologist. 1999;4(2):87-94.
4
Maintenance chemotherapy with oral treosulfan following first-line treatment in patients with advanced ovarian cancer: feasibility and toxicity.晚期卵巢癌患者一线治疗后口服曲奥舒凡维持化疗：可行性与毒性
Anticancer Res. 1997 May-Jun;17(3C):2221-3.
5
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗：一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
6
Clinical observational study of conformal radiotherapy combined with topotecan chemotherapy in patients with platinum-resistant recurrent ovarian cancer.拓扑替康化疗联合适形放疗用于铂耐药复发性卵巢癌患者的临床观察研究
Genet Mol Res. 2015 Apr 22;14(2):3833-42. doi: 10.4238/2015.April.22.12.
7
Clinical experience with topotecan in relapsed ovarian cancer.
Gynecol Oncol. 2003 Sep;90(3 Pt 2):S3-7. doi: 10.1016/s0090-8258(03)00467-0.
8
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.每周拓扑替康治疗复发性卵巢、输卵管和原发性腹膜癌：耐受性和疗效研究——以色列经验。
Int J Gynecol Cancer. 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944.
9
Topotecan in platinum-resistant epithelial ovarian cancer.拓扑替康用于铂耐药上皮性卵巢癌
Chemotherapy. 2005 Oct;51(6):347-51. doi: 10.1159/000088959. Epub 2005 Oct 14.
10
Update on the role of topotecan in the treatment of recurrent ovarian cancer.拓扑替康在复发性卵巢癌治疗中作用的最新进展
Oncologist. 2002;7 Suppl 5:3-10. doi: 10.1634/theoncologist.7-suppl_5-3.

引用本文的文献

1
DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis.穿心莲内酯促进结肠上皮细胞中的DNA损伤修复，下调cGAS-STING途径的激活，并有助于缓解CPT-11诱导的肠道黏膜炎。
Acta Pharm Sin B. 2022 Jan;12(1):262-273. doi: 10.1016/j.apsb.2021.03.043. Epub 2021 Apr 29.

本文引用的文献

1
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).拓扑替康与烷化剂曲奥舒凡用于一线铂类/紫杉醇化疗后12个月内复发的上皮性卵巢癌患者的疗效对比。由妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究组（AGO-OVAR）进行的一项前瞻性随机III期试验。
Gynecol Oncol. 2009 Aug;114(2):199-205. doi: 10.1016/j.ygyno.2009.04.026. Epub 2009 May 14.
2
Pharmaceutical management of ovarian cancer : current status.卵巢癌的药物治疗：现状
Drugs. 2008;68(6):771-89. doi: 10.2165/00003495-200868060-00004.
3
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.腹腔内化疗用于Ⅲ期上皮性卵巢癌女性的一线治疗：一项Meta分析的系统评价
Cancer. 2007 Feb 15;109(4):692-702. doi: 10.1002/cncr.22466.
4
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.新诊断的II期、III期或IV期上皮性卵巢癌术后患者一线化疗的系统评价
Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552.